Skip to content

PET-CT to Assess Brain Damage in Cardiac Arrest Patients

Assessment of Cerebral Metabolism, Cerebral Blood Flow and Cerebral Oxygen Damage in Patients With Cardiac Arrest Using PET-CT

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06660238
Enrollment
30
Registered
2024-10-28
Start date
2025-05-01
Completion date
2027-12-31
Last updated
2025-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Cardiac Arrest

Keywords

Cardiac arrest, Positron Emission Tomography-Computed Tomography, cerebral metabolism, cerebral blood flow, cerebral oxygenation

Brief summary

This was a single-center, observational study. Patients with successful cardiopulmonary resuscitation (CPR) will be transferred to the emergency intensive care unit for further standardized management. After successful return of spontaneous circulation (ROSC) for 72 hours and hemodynamic stability for 24 hours, the patients underwent positron emission computed tomography (PET-CT) examination after resuscitation. The supervising physician accompanied the patient and used monitors to monitor vital signs during the examination. Patients who were on ventilators were mechanically ventilated with a magnetic ventilator (HAMILTON-MRI, United States). In addition to conventional cerebral oxygen metabolism, cerebral blood flow, oxygen extraction fraction, cerebral blood volume and other indicators were added in this experiment. These indicators can evaluate the patient's cerebral metabolism, cerebral blood flow and cerebral blood oxygen damage degree. The neurological outcome was followed up 6 months after onset according to the cerebral performance category(CPC).

Interventions

OTHERNo interventions

No interventions

Sponsors

Capital Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age ≥18 years. * sustained hemodynamic stability for ≥24h. * the patients were unconscious and not able to obey verbal commands. • Advanced life support and target temperature management within 6 hours of return of spontaneous circulation (ROSC).

Exclusion criteria

* Patients with hemodynamic instability. * Patients who could not complete cranial PET-CT examination for special reasons. • Patients during pregnancy. * Patients who combined traumatic brain injury, stroke, cerebral hemorrhage and other diseases. * Patients whose family members did not agree to be enrolled.

Design outcomes

Primary

MeasureTime frameDescription
Neurologic prognosis6 monthsPatients will be followed up for neurologic prognosis according to the Cerebral Performance Category Scale(CPC)at 6 months after disease onset.The CPC score was divided into five grades. Grade 1 represented intact brain function, the patient was awake and alert, and had the ability to live and work normally. Grade 2 represents moderate cerebral disability, in which the person is awake and able to work part of the time in a specific environment or perform daily activities independently; Grade 3, severe cerebral disability: the person is awake but dependent on others for daily assistance and retains limited cognition; Grade 4 represents coma and vegetative state, the patient is unconscious, unconscious to the environment, and has no cognitive ability; Level 5 represents death, with the patient confirmed as brain death or death by traditional criteria. According to the CPC score, grade 1-2 was defined as good neurological outcome, and grade 3-5 was defined as poor neurological outcome.

Countries

China

Contacts

Primary ContactZiren Tang
tangziren1970@163.com+86 010-85231530

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026